RT Journal Article
SR Electronic
T1 Psychiatric symptoms and syndromes transcending diagnostic boundaries in Indian multiplex families: The cohort of ADBS study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.01.06.20016543
DO 10.1101/2020.01.06.20016543
A1 Vanteemar S Sreeraj
A1 Bharath Holla
A1 Dhruva Ithal
A1 Ravi Kumar Nadella
A1 Jayant Mahadevan
A1 Srinivas Balachander
A1 Furkhan Ali
A1 Sweta Sheth
A1 Janardhanan C. Narayanaswamy
A1 Ganesan Venkatasubramanian
A1 John P. John
A1 Mathew Varghese
A1 Vivek Benegal
A1 Sanjeev Jain
A1 YC Janardhan Reddy
A1 ADBS Consortium
A1 Biju Viswanath
YR 2020
UL http://medrxiv.org/content/early/2020/02/20/2020.01.06.20016543.abstract
AB Accelerator program for discovery in brain disorders using stem cells (ADBS) is an ongoing longitudinal study investigating the neurobiological aspects of five psychiatric disorders (Alzheimer’s dementia, bipolar disorder, obsessive-compulsive disorder, substance use disorder or schizophrenia) in India. The study uses several techniques (brain-imaging, psychophysics, neuropsychology, next-generation sequencing, cellular models), and in-depth clinical assessments in a longitudinal cohort from multiple-affected families. This article explores the frequency of manifestations of different psychiatric symptoms and syndromes in the participants and their relatives from the first wave of this study (August 2016 to October 2019). We screened 3,583 families and enrolled 481 families (1406 participants; 773 affected with any of the 5 disorders, and 633 relatives). The participants had a high familial prevalence with nearly a third of FDRs affected. Though similar disorders aggregated, the majority (61%) of the families had dissimilar diagnoses among members. Moreover, 15% of affected participants had two or more co-occurring syndromes. Diverse cross-cutting symptoms, unrestricted to the index syndrome, were observed in participants across diagnostic categories. The pattern and extent of co-occurrence validate the need for a transdiagnostic approach. The repository of biomaterials as well as digital datasets will serve as a valuable resource for the larger scientific community.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-018-1674-2 Funding StatementThis research is funded by the Accelerator program for discovery in brain disorders using stem cells (ADBS) (Funded by the Department of Biotechnology, Government of India).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be available on reasonable request.